Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 4/20 | 0.44 |
| ▸ | THRA | P10827 | 2/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15027319 | 0.95 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1DGKATHRBTHRA | |
| SCHEMBL15028017 | 0.95 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1DGKATHRBTHRA | |
| SCHEMBL17123950 | 0.95 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1DGKATHRBTHRA | |
| SCHEMBL15027821 | 0.95 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1DGKATHRBTHRA | |
| SCHEMBL15027866 | 0.95 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1DGKATHRBTHRA | |
| SCHEMBL15027795 | 0.95 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1DGKATHRBTHRA | |
| SCHEMBL15027156 | 0.95 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1DGKATHRBTHRA | |
| SCHEMBL19034662 | 0.94 | ALDH1A1 (0.51) | ALDH1A1L3MBTL1DGKATHRBTHRA | |
| SCHEMBL15148562 | 0.94 | ALDH1A1 (0.58) | ALDH1A1L3MBTL1DGKATHRBTHRA | |
| SCHEMBL15027916 | 0.94 | ALDH1A1 (0.58) | ALDH1A1L3MBTL1DGKATHRBTHRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220347302-A1 | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | ALNYLAM PHARMACEUTICALS, INC. | 2022-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220347302-A1 | BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS | LIPA, APOB, CETP | ALDH1A1 3151/4885L3MBTL1 1228/4885DGKA 352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.